Determinants of the Response to BTK Degraders (BTKd) in Double Refractory Chronic Lymphocytic Leukemia (CLL)
NCT07099443 · RECRUITING · N/A
We track 2 ClinicalTrials.gov studies led by Nantes University Hospital. The portfolio skews toward N/A (2 trials).
2 clinical trials sponsored by Nantes University Hospital.
| Phase | Trials | Distribution |
|---|---|---|
| N/A | 2 | 100% |
Nantes University Hospital currently sponsors 2 clinical trials tracked on ReadTheTrial. These span N/A.
Nantes University Hospital conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Nantes University Hospital currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.